Virbac SA Logo

Virbac SA

VIRP.PA

(2.8)
Stock Price

400,00 EUR

11.8% ROA

13.49% ROE

24.59x PER

Market Cap.

2.971.250.600,00 EUR

10.77% DER

0.37% Yield

9.73% NPM

Virbac SA Stock Analysis

Virbac SA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Virbac SA Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (15.59%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (11%), which means it has a small amount of debt compared to the ownership it holds

4 PBV

The stock's PBV ratio (2.78x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 Dividend Growth

Investors can be encouraged by the company's strong dividend growth over the past three years, highlighting its ability to generate consistent returns and provide an attractive investment opportunity.

7 Dividend

The company has consistently provided dividends over the past three years, indicating a reliable source of income for investors.

8 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (3.781), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

9 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

11 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

Virbac SA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Virbac SA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Virbac SA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Virbac SA Revenue
Year Revenue Growth
2002 367.936.000
2003 354.757.000 -3.71%
2004 351.404.000 -0.95%
2005 372.403.000 5.64%
2006 401.636.000 7.28%
2007 438.548.000 8.42%
2008 443.355.000 1.08%
2009 467.418.000 5.15%
2010 572.830.000 18.4%
2011 623.059.000 8.06%
2012 695.155.000 10.37%
2013 736.079.000 5.56%
2014 773.116.000 4.79%
2015 852.623.000 9.32%
2016 871.829.000 2.2%
2017 861.881.000 -1.15%
2018 868.932.000 0.81%
2019 938.342.000 7.4%
2020 934.199.000 -0.44%
2021 1.063.966.000 12.2%
2022 1.216.187.000 12.52%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Virbac SA Research and Development Expenses
Year Research and Development Expenses Growth
2002 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 13.102.000 100%
2019 14.814.000 11.56%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Virbac SA General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 0
2003 0 0%
2004 1.297.000 100%
2005 1.486.000 12.72%
2006 1.603.000 7.3%
2007 0 0%
2008 116.996.000 100%
2009 233.863.000 49.97%
2010 138.747.000 -68.55%
2011 13.642.000 -917.06%
2012 158.741.000 91.41%
2013 158.961.000 0.14%
2014 164.559.000 3.4%
2015 208.141.000 20.94%
2016 181.927.000 -14.41%
2017 179.029.000 -1.62%
2018 0 0%
2019 0 0%
2020 158.692.000 100%
2021 203.465.000 22.01%
2022 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Virbac SA EBITDA
Year EBITDA Growth
2002 40.815.000
2003 32.579.000 -25.28%
2004 39.612.000 17.75%
2005 54.865.000 27.8%
2006 57.284.000 4.22%
2007 63.913.000 10.37%
2008 68.797.000 7.1%
2009 74.490.000 7.64%
2010 106.973.000 30.37%
2011 106.532.000 -0.41%
2012 122.656.000 13.15%
2013 126.024.000 2.67%
2014 142.783.000 11.74%
2015 80.929.000 -76.43%
2016 120.696.000 32.95%
2017 107.587.000 -12.18%
2018 111.864.000 3.82%
2019 152.420.000 26.61%
2020 181.427.000 15.99%
2021 216.962.000 16.38%
2022 233.704.000 7.16%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Virbac SA Gross Profit
Year Gross Profit Growth
2002 367.936.000
2003 354.757.000 -3.71%
2004 235.223.000 -50.82%
2005 162.791.000 -44.49%
2006 174.574.000 6.75%
2007 293.798.000 40.58%
2008 298.309.000 1.51%
2009 315.876.000 5.56%
2010 391.052.000 19.22%
2011 282.259.000 -38.54%
2012 479.657.000 41.15%
2013 504.663.000 4.95%
2014 528.510.000 4.51%
2015 554.771.000 4.73%
2016 571.677.000 2.96%
2017 558.443.000 -2.37%
2018 574.643.000 2.82%
2019 620.110.000 7.33%
2020 617.563.000 -0.41%
2021 712.852.000 13.37%
2022 794.994.000 10.33%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Virbac SA Net Profit
Year Net Profit Growth
2002 39.783.000
2003 27.545.000 -44.43%
2004 16.726.000 -64.68%
2005 19.799.000 15.52%
2006 24.913.000 20.53%
2007 31.873.000 21.84%
2008 36.287.000 12.16%
2009 39.676.000 8.54%
2010 64.313.000 38.31%
2011 58.555.000 -9.83%
2012 66.625.000 12.11%
2013 60.523.000 -10.08%
2014 63.596.000 4.83%
2015 9.405.000 -576.19%
2016 34.646.000 72.85%
2017 -2.575.000 1445.48%
2018 20.099.000 112.81%
2019 54.234.000 62.94%
2020 137.465.000 60.55%
2021 113.162.000 -21.48%
2022 121.967.000 7.22%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Virbac SA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 5
2003 3 -33.33%
2004 2 -50%
2005 2 0%
2006 3 0%
2007 4 33.33%
2008 4 25%
2009 4 0%
2010 7 42.86%
2011 7 -16.67%
2012 8 14.29%
2013 7 0%
2014 8 0%
2015 1 -600%
2016 4 75%
2017 0 0%
2018 2 100%
2019 6 66.67%
2020 16 62.5%
2021 13 -23.08%
2022 14 7.14%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Virbac SA Free Cashflow
Year Free Cashflow Growth
2002 22.131.000
2003 -9.173.000 341.26%
2004 15.707.000 158.4%
2005 26.155.000 39.95%
2006 36.586.000 28.51%
2007 33.599.000 -8.89%
2008 23.658.000 -42.02%
2009 42.581.000 44.44%
2010 58.963.000 27.78%
2011 18.460.000 -219.41%
2012 61.159.000 69.82%
2013 14.338.000 -326.55%
2014 36.335.000 60.54%
2015 3.685.000 -886.02%
2016 102.416.000 96.4%
2017 69.564.000 -47.23%
2018 49.754.000 -39.82%
2019 27.154.000 -83.23%
2020 89.925.000 69.8%
2021 82.737.000 -8.69%
2022 45.407.000 -82.21%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Virbac SA Operating Cashflow
Year Operating Cashflow Growth
2002 30.923.000
2003 26.572.000 -16.37%
2004 41.304.000 35.67%
2005 35.764.000 -15.49%
2006 48.807.000 26.72%
2007 50.451.000 3.26%
2008 42.280.000 -19.33%
2009 64.778.000 34.73%
2010 83.897.000 22.79%
2011 61.781.000 -35.8%
2012 97.033.000 36.33%
2013 73.633.000 -31.78%
2014 76.447.000 3.68%
2015 46.221.000 -65.39%
2016 142.449.000 67.55%
2017 107.806.000 -32.13%
2018 83.623.000 -28.92%
2019 32.902.250 -154.16%
2020 120.896.000 72.78%
2021 129.904.000 6.93%
2022 98.984.000 -31.24%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Virbac SA Capital Expenditure
Year Capital Expenditure Growth
2002 8.792.000
2003 35.745.000 75.4%
2004 25.597.000 -39.65%
2005 9.609.000 -166.39%
2006 12.221.000 21.37%
2007 16.852.000 27.48%
2008 18.622.000 9.5%
2009 22.197.000 16.11%
2010 24.934.000 10.98%
2011 43.321.000 42.44%
2012 35.874.000 -20.76%
2013 59.295.000 39.5%
2014 40.112.000 -47.82%
2015 42.536.000 5.7%
2016 40.033.000 -6.25%
2017 38.242.000 -4.68%
2018 33.869.000 -12.91%
2019 5.748.250 -489.21%
2020 30.971.000 81.44%
2021 47.167.000 34.34%
2022 53.577.000 11.96%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Virbac SA Equity
Year Equity Growth
2002 101.564.000
2003 108.001.000 5.96%
2004 122.437.000 11.79%
2005 148.075.000 17.31%
2006 162.745.000 9.01%
2007 182.242.000 10.7%
2008 198.420.000 8.15%
2009 233.605.000 15.06%
2010 300.062.000 22.15%
2011 311.385.000 3.64%
2012 346.169.000 10.05%
2013 360.930.000 4.09%
2014 430.930.000 16.24%
2015 438.410.000 1.71%
2016 473.628.000 7.44%
2017 436.346.000 -8.54%
2018 495.874.000 12%
2019 551.879.000 10.15%
2020 657.178.000 16.02%
2021 725.191.000 9.38%
2022 838.983.000 13.56%
2023 897.908.000 6.56%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Virbac SA Assets
Year Assets Growth
2002 266.742.000
2003 285.313.000 6.51%
2004 294.133.000 3%
2005 314.323.000 6.42%
2006 378.865.000 17.04%
2007 376.637.000 -0.59%
2008 412.656.000 8.73%
2009 434.470.000 5.02%
2010 533.753.000 18.6%
2011 588.635.000 9.32%
2012 827.698.000 28.88%
2013 896.232.000 7.65%
2014 1.325.842.000 32.4%
2015 1.430.550.000 7.32%
2016 1.417.161.000 -0.94%
2017 1.277.332.000 -10.95%
2018 1.272.807.000 -0.36%
2019 1.323.259.000 3.81%
2020 1.111.461.000 -19.06%
2021 1.201.551.000 7.5%
2022 1.333.511.000 9.9%
2023 1.420.614.000 6.13%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Virbac SA Liabilities
Year Liabilities Growth
2002 134.224.000
2003 156.228.000 14.08%
2004 162.963.000 4.13%
2005 154.136.000 -5.73%
2006 213.937.000 27.95%
2007 192.352.000 -11.22%
2008 211.643.000 9.11%
2009 198.270.000 -6.74%
2010 231.399.000 14.32%
2011 274.769.000 15.78%
2012 429.282.000 35.99%
2013 481.858.000 10.91%
2014 844.064.000 42.91%
2015 948.260.000 10.99%
2016 896.374.000 -5.79%
2017 798.489.000 -12.26%
2018 776.933.000 -2.77%
2019 771.380.000 -0.72%
2020 454.283.000 -69.8%
2021 476.360.000 4.63%
2022 494.528.000 3.67%
2023 522.706.000 5.39%

Virbac SA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
143.96
Net Income per Share
14.44
Price to Earning Ratio
24.59x
Price To Sales Ratio
2.44x
POCF Ratio
30.3
PFCF Ratio
65.44
Price to Book Ratio
3.57
EV to Sales
2.37
EV Over EBITDA
12.34
EV to Operating CashFlow
29.14
EV to FreeCashFlow
63.52
Earnings Yield
0.04
FreeCashFlow Yield
0.02
Market Cap
2,97 Bil.
Enterprise Value
2,88 Bil.
Graham Number
179.65
Graham NetNet
-17.96

Income Statement Metrics

Net Income per Share
14.44
Income Quality
0.82
ROE
0.16
Return On Assets
0.08
Return On Capital Employed
0.16
Net Income per EBT
0.7
EBT Per Ebit
1.01
Ebit per Revenue
0.14
Effective Tax Rate
0.31

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.34
Operating Profit Margin
0.14
Pretax Profit Margin
0.14
Net Profit Margin
0.1

Dividends

Dividend Yield
0
Dividend Yield %
0.37
Payout Ratio
0.09
Dividend Per Share
1.32

Operating Metrics

Operating Cashflow per Share
11.72
Free CashFlow per Share
5.37
Capex to Operating CashFlow
-0.54
Capex to Revenue
-0.04
Capex to Depreciation
-1.09
Return on Invested Capital
0.13
Return on Tangible Assets
0.12
Days Sales Outstanding
0
Days Payables Outstanding
135.03
Days of Inventory on Hand
286.76
Receivables Turnover
0
Payables Turnover
2.7
Inventory Turnover
1.27
Capex per Share
-6.34

Balance Sheet

Cash per Share
21,00
Book Value per Share
99,35
Tangible Book Value per Share
63.86
Shareholders Equity per Share
99.35
Interest Debt per Share
11.14
Debt to Equity
0.11
Debt to Assets
0.07
Net Debt to EBITDA
-0.37
Current Ratio
1.85
Tangible Asset Value
0,54 Bil.
Net Current Asset Value
0,23 Bil.
Invested Capital
0.11
Working Capital
0,33 Bil.
Intangibles to Total Assets
0.22
Average Receivables
0,00 Bil.
Average Payables
0,14 Bil.
Average Inventory
300620500
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Virbac SA Dividends
Year Dividends Growth
1992 9
1993 9 0%
1994 10 11.11%
1995 8 -12.5%
1996 9 11.11%
1997 9 0%
1998 10 10%
1999 2 -900%
2000 2 0%
2001 2 50%
2002 2 0%
2003 1 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 2 100%
2009 1 -100%
2010 1 0%
2011 2 0%
2012 2 0%
2013 2 0%
2014 2 0%
2015 2 0%
2021 1 0%
2022 1 100%
2023 1 0%

Virbac SA Profile

About Virbac SA

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

CEO
Mr. Sebastien Huron
Employee
5.386
Address
13e rue LID - BP 27
Carros, 06511

Virbac SA Executives & BODs

Virbac SA Executives & BODs
# Name Age
1 Mr. Bertrand Havrileck
Head of Corporate R&D
70
2 Mr. Marc Bistuer
Deputy Chief Executive Officer and Director of Corporate Quality & Compliance
70
3 Ms. Nathalie Pollet
Head of Global Marketing & Market Development
70
4 Ms. Sophie Favini
Head of Global Business Operations
70
5 Ms. Sandrine Brunel
Head of Corporate Communications
70
6 Ms. Francesca Cortella
Head of Corporate Human Resources
70
7 Mr. Sebastien Huron
Chief Executive Officer & Chairman of the Executive Board
70
8 Mr. Habib Ramdani
Chief Financial Officer, Deputy Chief Executive Officer & Member of Executive Board
70
9 Manuela Rodríguez
Director of Financial Projects
70

Virbac SA Competitors

Vetoquinol SA Logo
Vetoquinol SA

VETO.PA

(2.2)
Trigano S.A. Logo
Trigano S.A.

TRI.PA

(3.8)
bioMérieux S.A. Logo
bioMérieux S.A.

BIM.PA

(2.2)
Ipsen S.A. Logo
Ipsen S.A.

IPN.PA

(3.0)